Neurocrine Biosciences, Inc.NBIXNASDAQ
Loading
Cost of Revenue Over TimeExpanding
Percentile Rank100
3Y CAGR+31.0%
5Y CAGR+38.8%
Year-over-Year Change
Direct costs attributable to producing goods sold
3Y CAGR
+31.0%/yr
vs +47.5%/yr prior
5Y CAGR
+38.8%/yr
Recent deceleration
Acceleration
-16.6pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
5.2x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $52.10M | +53.2% |
| 2024 | $34.00M | -14.4% |
| 2023 | $39.70M | +71.1% |
| 2022 | $23.20M | +62.2% |
| 2021 | $14.30M | +41.6% |
| 2020 | $10.10M | +36.5% |
| 2019 | $7.40M | +51.0% |
| 2018 | $4.90M | +290.7% |
| 2017 | $1.25M | - |
| 2016 | $0.00 | - |